This year’s Conference on Retroviruses and Opportunistic Infections (CROI) features several sessions discussing prevention ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...
The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It's a good economic investment, says the Fund's Peter Sands, into a ...
Funding Gaps: There is a funding gap of USD 1.9 million for procuring 30,000 three-month ART courses needed to sustain treatment through 2025. Ukraine’s Public Health Centre may request a state budget ...